Impact of Thrombus Length on Outcomes after Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial
Stroke , Volume 48 - Issue 7 p. 1895- 1900
Background and Purpose - Increasing thrombus length (TL) impedes recanalization after intravenous (IV) thrombolysis. We sought to determine whether the clinical benefit of aspiration thrombectomy relative to IV r-tPA (recombinant tissue-type plasminogen activator) may be greater at longer TL. Methods - THERAPY was a randomized trial of aspiration thrombectomy plus IV r-tPA versus IV r-tPA alone in large-vessel stroke patients with prospective TL measurement ≥8 mm. In this post hoc study, we evaluated the association of TL with trial end points and potential endovascular treatment effect, using univariate, multivariable, and multiplicative interaction analyses. Results - TL data were available for all 108 patients (28% internal carotid artery, 62% M1, and 10% M2). Median TL was 14.0 mm (interquartile range, 9.7-19.5 mm). Longer TL was associated with worse outcome (90-day modified Rankin Scale score: odds ratio, 1.24 per 5-mm TL increment; 95% confidence interval, 1.04-1.52; P=0.02), even after adjusting for key outcome predictors (adjusted P=0.004). Longer TL was also associated with more serious adverse events (adjusted P=0.01), more symptomatic hemorrhages (adjusted P=0.03), and increased mortality (adjusted P=0.01). No significant relationship was observed between TL and angiographic reperfusion (modified thrombolysis in cerebral ischemia 2b-3), but greater TL was associated with longer endovascular procedural times (ρ=0.36; P=0.045). Increasing TL was associated with greater aspiration thrombectomy treatment effect (interaction term P=0.03). This might be related to a potentially stronger adverse effect of increasing TL on 90-day modified Rankin Scale for patients treated with IV r-tPA (ρ=0.39; P=0.01) compared with intra-arterial therapy (ρ=0.20; P=0.165). Conclusions - Ischemic stroke patients with longer symptomatic thrombi have worse 90-day clinical outcomes but may have a greater relative benefit of aspiration thrombectomy over IV r-tPA alone. Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT01429350.
|middle cerebral artery, stroke, thrombectomy, thrombosis|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Yoo, A.J, Khatri, P, Mocco, J, Zaidat, O, Gupta, R. (Rishi), Frei, D. (Donald), … von Kummer, R. (2017). Impact of Thrombus Length on Outcomes after Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial. Stroke, 48(7), 1895–1900. doi:10.1161/STROKEAHA.116.016253